PP-203

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePP-203
Drug Alias NamePP-203
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBone modulators
TargetsNot applicable
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPacific Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPacific Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A